Announcements
Open Access
Review
Peri-Operative Changes of Inflammatory Markers and Their Implications in Pulmonary Endarterectomy
Show Less
1
School of Basic Medicine, Gansu University of Chinese Medicine, 730000 Lanzhou, Gansu, China
2
Department of Scientific Research Office, Gansu Provincial Hospital, 730000 Lanzhou, Gansu, China
3
Department of Pathology, The 940th Hospital of Joint Logistics Support Force of Chinese People's Liberation Army, 730050 Lanzhou, Gansu, China
4
Department of Cardiology, Gansu Provincial Hospital, 730000 Lanzhou, Gansu, China
5
Department of Scientific Research Office, Gansu Provincial Hospital, 730000 Lanzhou, Gansu, China
*Correspondence: yunshancao@126.com (Yunshan Cao); sallyzhangmin@126.com (Min Zhang)
Academic Editor: Vincenzo Lionetti
Academic Editor: Vincenzo Lionetti
Rev. Cardiovasc. Med. 2022, 23(11), 357;
https://doi.org/10.31083/j.rcm2311357
Submitted: 1 June 2022 | Revised: 17 August 2022 | Accepted: 29 August 2022 | Published: 25 October 2022
(This article belongs to the Special Issue Translational Perioperative Cardioprotection)
Copyright: © 2022 The Author(s). Published by IMR Press.
This is an open access article under the CC BY 4.0 license.
Abstract
Pulmonary endarterectomy (PEA) is used to treat chronic thromboembolic pulmonary hypertension (CTEPH) patients, and it can effectively remove organized thrombotic materials and proliferative intima as well as improve hemodynamics. It has been reported that the levels of several inflammatory factors were altered in the peri-operative period of PEA. Even though their specific role remains unknown, this could have some relevance. In this study, we reviewed the recently published data addressing these factors in PEA, attempting to understand their potential implications.
Keywords
inflammation
pulmonary endarterectomy
perioperative period
Figures
Fig. 1.